Peptide based vesicles for cancer immunotherapy: design, construction and applications

Area of Science:

• Oncology
• Immunology
• Biotechnology

Background:

• Cancer immunotherapy offers powerful treatment strategies but faces challenges like limited efficacy and autoimmune side effects.
• Cancer vaccines targeting neoantigens show promise for directing immune responses against tumors.
• Peptide-based and vesicle-based vaccines are gaining attention for personalized cancer vaccine development.

Purpose of the Study:

• To review the characteristics, classification, and applications of peptide-based and vesicle-based cancer vaccines.
• To summarize the design and construction of peptide-based vesicles.
• To analyze the clinical applications and obstacles of peptide-based vesicles in cancer therapy.

Main Methods:

• Literature review of existing research on cancer vaccines, particularly peptide-based and vesicle-based approaches.
• Analysis of vaccine design, construction, and biological applications.
• Evaluation of preclinical and clinical data on efficacy and safety.

Main Results:

• Peptide-based vesicles, modified with functional peptides, enhance immune response and anti-cancer effects.
• These vesicles demonstrate potent efficacy in various preclinical tumor models.
• The review covers diverse cancer types where peptide-based vesicles have been applied.

Conclusions:

• Peptide-based vesicles represent a promising platform for personalized cancer vaccines.
• Further research is needed to overcome key obstacles for successful clinical translation.
• Understanding their construction and application is crucial for advancing cancer immunotherapy.